QQQ   423.81 (-0.48%)
AAPL   167.08 (-0.55%)
MSFT   405.08 (-1.64%)
META   502.01 (+1.59%)
GOOGL   156.44 (+0.62%)
AMZN   179.38 (-1.05%)
TSLA   151.15 (-2.77%)
NVDA   845.77 (+0.64%)
AMD   154.58 (+0.36%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.25 (+0.81%)
F   12.01 (-0.25%)
MU   112.49 (-3.30%)
GE   153.69 (-1.27%)
CGC   8.08 (+24.50%)
DIS   112.96 (+0.02%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.38 (-0.21%)
QQQ   423.81 (-0.48%)
AAPL   167.08 (-0.55%)
MSFT   405.08 (-1.64%)
META   502.01 (+1.59%)
GOOGL   156.44 (+0.62%)
AMZN   179.38 (-1.05%)
TSLA   151.15 (-2.77%)
NVDA   845.77 (+0.64%)
AMD   154.58 (+0.36%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.25 (+0.81%)
F   12.01 (-0.25%)
MU   112.49 (-3.30%)
GE   153.69 (-1.27%)
CGC   8.08 (+24.50%)
DIS   112.96 (+0.02%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.38 (-0.21%)
QQQ   423.81 (-0.48%)
AAPL   167.08 (-0.55%)
MSFT   405.08 (-1.64%)
META   502.01 (+1.59%)
GOOGL   156.44 (+0.62%)
AMZN   179.38 (-1.05%)
TSLA   151.15 (-2.77%)
NVDA   845.77 (+0.64%)
AMD   154.58 (+0.36%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.25 (+0.81%)
F   12.01 (-0.25%)
MU   112.49 (-3.30%)
GE   153.69 (-1.27%)
CGC   8.08 (+24.50%)
DIS   112.96 (+0.02%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.38 (-0.21%)
QQQ   423.81 (-0.48%)
AAPL   167.08 (-0.55%)
MSFT   405.08 (-1.64%)
META   502.01 (+1.59%)
GOOGL   156.44 (+0.62%)
AMZN   179.38 (-1.05%)
TSLA   151.15 (-2.77%)
NVDA   845.77 (+0.64%)
AMD   154.58 (+0.36%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.25 (+0.81%)
F   12.01 (-0.25%)
MU   112.49 (-3.30%)
GE   153.69 (-1.27%)
CGC   8.08 (+24.50%)
DIS   112.96 (+0.02%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.38 (-0.21%)
NASDAQ:VMD

Viemed Healthcare (VMD) Stock Price, News & Analysis

$7.80
-0.02 (-0.26%)
(As of 03:15 PM ET)
Today's Range
$7.68
$7.96
50-Day Range
$7.82
$9.99
52-Week Range
$5.90
$12.01
Volume
66,400 shs
Average Volume
159,936 shs
Market Capitalization
$302.33 million
P/E Ratio
30.00
Dividend Yield
N/A
Price Target
N/A
VMD stock logo

About Viemed Healthcare Stock (NASDAQ:VMD)

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

VMD Stock Price History

VMD Stock News Headlines

This Little-Known Stock Controls the Future of AI
#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'
This Little-Known Stock Controls the Future of AI
#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'
Viemed Healthcare Inc.
Should You Hold Viemed Healthcare (VMD)?
Viemed Healthcare Inc Ordinary Shares
Viemed Healthcare Inc Ordinary Shares VMD
Viemed Healthcare Q3 2023 Earnings Preview
3 Medical Stocks Investors Are Buying for Growth
Closing Bell: Viemed Healthcare Inc flat on Thursday (VMD)
See More Headlines
Receive VMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viemed Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/06/2024
Today
4/18/2024
Next Earnings (Estimated)
5/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:VMD
Fax
N/A
Employees
996
Year Founded
N/A

Profitability

Net Income
$10.24 million
Pretax Margin
7.86%

Debt

Sales & Book Value

Annual Sales
$183.01 million
Cash Flow
$0.79 per share
Book Value
$2.96 per share

Miscellaneous

Free Float
31,316,000
Market Cap
$303.10 million
Optionable
Not Optionable
Beta
1.51
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Casey Hoyt (Age 47)
    CEO & Director
    Comp: $921.36k
  • Mr. Michael B. Moore CRT (Age 47)
    President
    Comp: $808.11k
  • Mr. Trae Paul Fitzgerald (Age 35)
    Chief Financial Officer
    Comp: $409.57k
  • Mr. William Todd Zehnder (Age 49)
    COO & Director
    Comp: $791.77k
  • Dr. William Dana Frazier M.D. (Age 66)
    Chief Medical Officer & Director
    Comp: $255.71k
  • Mr. Jeremy Trahan
    Chief Legal Officer and Executive VP of Acquisitions & Strategic Transactions
  • Mr. Michael Freeman
    Chief Business Development Officer
  • Mr. Patrick Ewell Eagan (Age 45)
    General Counsel & Corporate Secretary

VMD Stock Analysis - Frequently Asked Questions

How have VMD shares performed in 2024?

Viemed Healthcare's stock was trading at $7.85 at the start of the year. Since then, VMD stock has decreased by 0.6% and is now trading at $7.80.
View the best growth stocks for 2024 here
.

Are investors shorting Viemed Healthcare?

Viemed Healthcare saw a increase in short interest in March. As of March 31st, there was short interest totaling 406,200 shares, an increase of 100.6% from the March 15th total of 202,500 shares. Based on an average trading volume of 167,200 shares, the days-to-cover ratio is currently 2.4 days. Approximately 1.2% of the shares of the company are sold short.
View Viemed Healthcare's Short Interest
.

When is Viemed Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our VMD earnings forecast
.

How were Viemed Healthcare's earnings last quarter?

Viemed Healthcare, Inc. (NASDAQ:VMD) issued its earnings results on Wednesday, March, 6th. The company reported $0.09 EPS for the quarter. The firm had revenue of $50.74 million for the quarter. Viemed Healthcare had a trailing twelve-month return on equity of 9.59% and a net margin of 5.60%.

What guidance has Viemed Healthcare issued on next quarter's earnings?

Viemed Healthcare updated its first quarter 2024 earnings guidance on Wednesday, March, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $49.7 million-$51.0 million, compared to the consensus revenue estimate of $51.9 million.

Who are Viemed Healthcare's major shareholders?

Viemed Healthcare's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Salem Investment Counselors Inc. (0.19%). Insiders that own company stock include Nitin Kaushal and Timothy Smokoff.
View institutional ownership trends
.

How do I buy shares of Viemed Healthcare?

Shares of VMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:VMD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners